The 2013 German Patients’ Rights Act – Codifying Medical Malpractice Compensation

Stauch, Marc

doi:10.1515/jetl-2015-0004

Cited by 3 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Even though the effect sizes for these associations were small, the observed dissatisfaction with ISM information is important to address due to the possible implications for adherence behavior. From a risk–benefit point of view, providing information entails little harm for the patient and comes at a feasible cost for the health care system with potential benefits for adherence behavior; it is also a contentious issue since it is the legal duty of health care providers to educate patients comprehensively (10). Current information provision seems to have a generic patient in mind, not adequately taking the individual patient’s viewpoint and needs into account.…”

Section: Resultsmentioning

confidence: 99%

“…As Bertram et al (9) fittingly phrased, “How can you be adherent if you don’t know how?” Health care providers are accordingly advised by worldwide KTx clinical practice guidelines to provide appropriate information about treatment and prescribed medicines (4, 7). From a legal perspective, this standard has been embedded for all illnesses in the German Patients’ Rights Act in 2013 (10). Relevant literature on this subject observes, however, substantial knowledge gaps in patients taking medicines regularly.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Information Needs of Patients About Immunosuppressive Medication in a German Kidney Transplant Sample: Prevalence and Correlates

et al. 2019

View full text Add to dashboard Cite

Background: Worldwide clinical guidelines for the care of kidney transplant (KT) recipients recognize the importance of health care providers imparting appropriate immunosuppressive medication (ISM) information for the facilitation of safe medication self-management. The extent of medication information made available is, however, not necessarily what patients require to know about their prescribed medicines. A useful indicator for determining the quality of prescription practice is to what degree the provided information meets the personal needs of patients. No previous studies have focused on the ISM information needs of KT patients. This study aims to investigate how satisfied KT patients are with the provided ISM information and to examine the association between satisfaction levels and socio-demographic, psychosocial, and transplant-related variables. Materials and Methods: KT patients ( n = 440) were asked to complete a series of self-report questionnaires to evaluate the variables adherence, ISM experience, perceived social support, symptoms of anxiety, and depression, and transplant-related information (e.g., donation type). ISM information needs were assessed with the Satisfaction with Information about Medicines Scale (SIMS-D). Results: On average, 35.9% of the answers to the SIMS-D items indicated dissatisfaction with the received information; dissatisfaction was more prevalent for the SIMS-D subscale “potential problems” (46.1%) than the SIMS-D subscale “action and usage” (26.7%). On an individual item level, the dissatisfaction with information concerning ISM side effects on drowsiness (57.1%) and sex life (56.3%) was most notable. Higher satisfaction with ISM information was correlated with higher age, better adherence, higher perceived social support, and lower anxiety levels. Multiple linear regression analyses revealed that adherence, perceived social support, and age were independently associated with ISM information satisfaction. No associations were found with sex, educational level, partnership status, symptoms of depression, experience of side effects, and transplant-related variables. Discussion: The data indicate that a substantial proportion of KT patients have unmet ISM information needs, especially with regard to potential problems of ISM. Dissatisfaction with ISM information is a potential amendable risk factor for KT patients engaging in non-adherent behavior, thus justifying further research in this area. ISM information should be tailored to meet the individual needs of KT patients in order to promote optimal medication self-management and adherence behavior.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Information Needs of Patients About Immunosuppressive Medication in a German Kidney Transplant Sample: Prevalence and Correlates

et al. 2019

View full text Add to dashboard Cite

show abstract

“…957 The BGB confirmed the fundamental nature of medical liability as a form of liability governed by general provisions. 958 Liability for medical error was, and until the enactment of the Patientenrechtegesetz in 2013 would remain, governed by the general rules on liability, 957 Riegger (2007) 97; 85f; Stauch (2015). 958 Weinrich (1902) 34.…”

Section: Categorising Medical Error In the Bgbmentioning

confidence: 99%

The Development of Medical Liability in Germany, 1800–1945

McGrath¹

2019

View full text Add to dashboard Cite

This volume examines the development of medical liability in Germany during its intense formative period from 1800–1945. It focuses on how the fault requirement in civil law was conceptualised and applied to liability for errors in the diagnosis and treatment of a patient. By focusing on the development of the law, and how it related and responded to changes in the nature of medicine, medical practitioners and healthcare over this period, it uncovers a rich interaction between the legal and medical narratives concerning fault. It offers an account of legal development where the law and lawyers were deeply embedded in, and influenced by, the broader social context, identifying a gradual shift towards asserting the independence of courts from accepted medical narrative in the light of technological advances.

show abstract

Medical Liability in Europe at the Dawn of Cross-border Healthcare: Time to Reflect on the Possibility of Harmonising the Policies Regarding Medical Liability?

Panagiotou

2016

Eur J Health Law

View full text Add to dashboard Cite

Due to the incorporation of Directive 2011/24/eu into national legislations European citizens will seek cross-border healthcare services. However, medical errors are an inherent part of medical practice. Major differences in European redress systems might create an environment of legal uncertainty and reduce the confidence of patients in seeking cross-border healthcare. After assessing European citizens’ perception regarding errors, we will try to examine if the aforementioned uncertainty is clarified by the eu legislation. Given that formal harmonization measures have not been legislated, the total convergence of redress systems is currently infeasible. Nevertheless, Member States could achieve a natural convergence through the reform of their national rules and the gradual adoption of common principles. The article will try to propose these principles and emphasize the key objectives reform in this area should aim at, in order to be effective in both enhancing legal certainty and balancing conflicting goals.

show abstract

The 2013 German Patients’ Rights Act – Codifying Medical Malpractice Compensation

Cited by 3 publications

References 0 publications

Information Needs of Patients About Immunosuppressive Medication in a German Kidney Transplant Sample: Prevalence and Correlates

Information Needs of Patients About Immunosuppressive Medication in a German Kidney Transplant Sample: Prevalence and Correlates

The Development of Medical Liability in Germany, 1800–1945

Medical Liability in Europe at the Dawn of Cross-border Healthcare: Time to Reflect on the Possibility of Harmonising the Policies Regarding Medical Liability?

Contact Info

Product

Resources

About